New Article Unit: Clinical Trials BC

Health Research BC hosted a roundtable last November to advance the vision. Three priorities were selected to shape progress in BC’s clinical trials ecosystem for the coming year.

Continue reading “Advancing BC’s vision for clinical trials”

The recipients are recognized for their significant contributions to strengthening BC’s clinical trials ecosystem.

Continue reading “Robert Olson and Bernie Eigl honoured for their excellence in clinical trials”

Accessibility to clinical trials catalyzes change for a stronger health research system. Approaches for accessible clinical trials was the theme of the Clinical Trials BC Symposium in November 2023.

Continue reading “Symposium sparks new ideas to enhance clinical trial accessibility in British Columbia”

These awards honour individuals and organizations who have made significant contributions to strengthening the BC clinical trials ecosystem. Submit your nominations by December 10, 2023.

Continue reading “2024 Clinical Trials BC Awards now open for nominations”

The recipients are honoured for their significant contributions and impacts to the clinical trials community in BC and beyond.

Continue reading “Dr. Anne Junker and Victor Espinosa named 2023 Clinical Trials BC Awards recipients”

The objective of this request is to fund trials evaluating products from Canadian-controlled biotechnology companies in partnership with ACT Network clinical trialists.

Continue reading “Call for proposals: Evaluate Canadian Biotechnologies with Randomized Controlled Trials”

We’re pleased to announce a renewed province-wide membership agreement with N2 (Network of Networks).

Continue reading “N2 province-wide membership renewed for 2023-2024”

The US Federal Drug Administration released a new draft document titled ‘Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers” on March 12, 2023

Continue reading “Regulatory update: Spring 2023”

Questions: What is the definition of a true or certified copy in Canada? Are we allowed to transfer the Clinical Trial Essential Records from the original medium to another media during the study and at the time of archive?

Continue reading “ASK JEAN column: copying or transfer of clinical trial records to a secondary medium”

Question: Do investigators and institutions have to provide direct access to source data and documents related to a clinical trial monitoring, REB review, audits, and regulatory inspection?

Continue reading “ASK JEAN Column: direct access to source data and documents”